Dr. Birgit Vogel and Dr. C. Michael Gibson Discuss: Sex-Specific Outcomes In High-Risk Patients Receiving Ticagrelor With Or Without Aspirin After Percutaneous Coronary Intervention: Results From The Twilight Study